Sunpeaks Ventures Announces Strategic Sales and Marketing Agreement with Acosta

SILVER SPRING, Md., April 2, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that the Company has entered into a strategic sales and marketing agreement with Acosta Sales & Marketing ("Acosta"), one of the leading sales and marketing agencies in the consumer packaged goods industry.

"This is a major accomplishment for Clotamin. One only needs to look at the long list of recognized brands that Acosta currently represents to get an idea of why we wanted to partner with them as our strategic sales and marketing firm," stated Mackie A. Barch, CEO of Sunpeaks.  "Acosta has a long established track record of helping to grow products into major national brands.  We look forward to working with them to introduce Clotamin to new retailers and potential consumers across the country."

Acosta represents thousands of the most important brands in the United States and has developed relationships with many of the nation's largest retailers.  Acosta has over $50 billion in system wide annual sales and close to 20,000 associates that call on over 100,000 retail stores per month.  Acosta represents more #1 and #2 brands in North America than any other agency. Current Acosta clients range from Campbell's to Procter & Gamble, and retail customers range from Giant to Walmart.  

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit www.sunpeaksventures.com.

Contact: Financial Insights 888-248-8491 or [email protected]

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements.  These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements.  The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission.  All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement.  Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

SOURCE Sunpeaks Ventures, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED